Antony Mattessich has been actively involved in trading Ocular Therapeutix stocks, signaling his confidence in the company's potential. Notably, in December 2020, he recorded a significant trading volume, with holdings peaking at around $2 million. In 2021, his trades fluctuated,...
Antony Mattessich has been actively involved in trading Ocular Therapeutix stocks, signaling his confidence in the company's potential. Notably, in December 2020, he recorded a significant trading volume, with holdings peaking at around $2 million. In 2021, his trades fluctuated, with his largest being over $1.35 million, illustrating his commitment to Ocular's growth. 2022 saw a considerable increase in activity, with his trades reaching as high as $4.72 million, showing a robust belief in the company's direction. However, by 2023, while his holdings still remained substantial, there was a noticeable adjustment, with transactions averaging around the $2 million mark. Overall, Mattessich's trading behavior reveals a keen insight into Ocular's business dynamics and future prospects.